Galleri Testing

Early Cancer Detection with the Galleri Test

Detecting cancer early can significantly improve treatment outcomes and survival rates. The Galleri Test, developed by Grail, is an advanced multi-cancer early detection test that identifies a cancer signal across more than 50 types of cancers, often before symptoms appear.

What is the Galleri Test?

The Galleri Test uses cutting-edge genomic technology to analyze DNA in your bloodstream for cancer-associated markers. This non-invasive blood test is designed to complement standard cancer screenings, detecting many cancers that are not typically screened for today.

How Does the Galleri Test Work?

The test looks for patterns of methylation—chemical changes in DNA that can indicate the presence of cancer. If a cancer signal is detected, the test provides information about where in the body the cancer may be located, helping guide further diagnostic workup.

Who Should Consider the Galleri Test?

• Individuals at Elevated Risk: People with a family history of cancer or other risk factors may benefit.
• Adults Over 50: As the risk of developing cancer increases with age, this test can provide an additional layer of protection.
• Those Seeking Comprehensive Screening: The Galleri Test can complement standard cancer screenings like mammograms or colonoscopies.

Key Benefits of the Galleri Test

• Early Detection: Identifies cancer in its earlier stages, improving the chance of successful treatment.
• Broad Coverage: Detects over 50 types of cancer, including many that are challenging to screen for using traditional methods.
• Non-Invasive: A simple blood draw is all that's required.
• Actionable Insights: If a signal is detected, it includes guidance for follow-up testing.